Sponsors’ participation in conduct and reporting of industry trials: a descriptive study

被引：0
|
作者：
Andreas Lundh
Lasse T Krogsbøll
Peter C Gøtzsche
机构：
[1] Rigshospitalet,The Nordic Cochrane Centre
[2] Dept.,Institute of Medicine and Surgery, Faculty of Health Sciences
[3] University of Copenhagen,undefined
来源：
Trials | / 13卷
关键词：
Randomised trials; Industry sponsorship; Academic authors; Trial protocols;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Quality of serious adverse events reporting to academic sponsors of clinical trials: far from optimal
    Crepin, Sabrina
    Villeneuve, Claire
    Merle, Louis
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (06) : 719 - 724
  • [22] Economics and industry do not mean ethical conduct in clinical trials
    Joel Lexchin
    Journal of Pharmaceutical Policy and Practice, 6 (1)
  • [23] Pharmaceutical industry's barriers and preferences to conduct clinical drug trials in Finland:: a qualitative study
    Keinonen, T
    Keränen, T
    Klaukka, T
    Saano, V
    Ylitalo, P
    Enlund, H
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 20 (01) : 35 - 42
  • [24] Completeness of reporting of trials published in languages other than English: Implications for conduct and reporting of systematic reviews
    Moher, D
    Fortin, P
    Jadad, AR
    Juni, P
    Klassen, T
    LeLorier, J
    Liberati, A
    Linde, K
    Penna, A
    LANCET, 1996, 347 (8998): : 363 - 366
  • [25] Quality of Abstracts Reporting in Periodontal Randomized Controlled Trials: A Descriptive Analysis
    Alharbi, Fahad
    Gufran, Khalid
    Ahmed, Muzammil M.
    Alghabban, Rawda O.
    Almohammadi, Mohammad Meish
    Almutairi, Abdullah S.
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2024, 16 (SUPPL 4) : S3322 - S3328
  • [26] Author Correction: Adaptive platform trials: definition, design, conduct and reporting considerations
    Nature Reviews Drug Discovery, 2019, 18 (10) : 808 - 808
  • [27] Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
    Petrou, Stavros
    Gray, Alastair
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [28] Controversies surround heart drug study questions about Vytorin and trial sponsors' conduct
    Mitka, Mike
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (08): : 885 - 887
  • [29] Sponsors' and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials
    Perez, Raymond
    Archdeacon, Patrick
    Roach, Nancy
    Goodwin, Robert
    Jarow, Jonathan
    Stuccio, Nina
    Forrest, Annemarie
    CLINICAL TRIALS, 2017, 14 (03) : 225 - 233
  • [30] A Descriptive Analysis of State Legislation and Policy Addressing Clinical Trials Participation
    Baquet, Claudia R.
    Mishra, Shiraz I.
    Weinberg, Armin D.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2009, 20 (02) : 24 - 39
12345